Recon: FDA to reduce number of studies needed for most drugs; CDC advisers delay vote on hepatitis B vaccine
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States